Estradiol-mediated tumor neo-vascularization

Oncology Letters

Volumn 2, Issue 3, 2011, Pages 453-457

  Rajoria, Shilpi ^a   Suriano, Robert ^a   Wilson, Yushan L ^b   George, Andrea L ^a   Geliebter, Jan ^a   Schantz, Stimson P ^b   Tiwari, Raj K ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b NEW YORK EYE AND EAR INFIRMARY   (United States)

Author keywords

Bone marrow endothelial progenitor cells; Estrogen; Neo vascularization

Indexed keywords

ANGIOPOIETIN RECEPTOR; ESTRADIOL; ESTROGEN; GREEN FLUORESCENT PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CANCER CELL; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FEMALE; HUMAN; HUMAN CELL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; ORTHOTOPIC TRANSPLANTATION; OVARIECTOMY; TUMOR LOCALIZATION; TUMOR VASCULARIZATION;

EID: 79953279957     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.283     Document Type: Article

References (30)

1. Lord RS, Bongiovanni B and Bralley JA: Estrogen metabolism and the diet-cancer connection: rationale for assessing the ratio of urinary hydroxylated estrogen metabolites. Altern Med Rev 7: 112-129, 2002.
2. He YY, Cai B, Yang YX, Liu XL and Wan XP: Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway. Cancer Sci 100: 1051-1061, 2009.
3. Vijayanathan V, Venkiteswaran S, Nair SK, Verma A, Thomas TJ, Zhu BT and Thomas T: Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17β-estradiol in human breast cancer cells. Clin Cancer Res 12: 2038-2048, 2006.
4. Lewis-Wambi JS and Jordan VC: Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit? Breast Cancer Res 11: 206, 2009.
5. Ciocca DR and Fanelli MA: Estrogen receptors and cell proliferation in breast cancer. Trends Endocrinol Metab 8: 313-321, 1997.
6. Song RX and Santen RJ: Membrane initiated estrogen signaling in breast cancer. Biol Reprod 75: 9-16, 2006.
7. Hua K, Feng W, Cao Q, Zhou X, Lu X and Feng Y: Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer. Int J Oncol 33: 959-967, 2008.
8. Pietras RJ: Interaction between estrogen and growth factor receptors in human breast cancers and tumor-associated vasculature. Breast J 9: 361-373, 2003.
9. Losordo DW and Isner JM: Estrogen and angiogenesis: A review. Arterioscler Thromb Vasc Biol 21: 6-12, 2001.
10. Risau W: Mechanism of angiogenesis. Nature 386: 671-674, 1997.
11. Aghi M and Chiocca EA: Contribution of bone marrow-derived cells to blood vessels in ischemic tissues and tumors. Mol Ther 6: 994-1005, 2005.
12. Young PP, Vaughan DE and Hatzopoulos AK: Biological properties of endothelial progenitor cells (EPCs) and their potential for cell therapy. Prog Cardiovasc Dis 49: 421-429, 2007.
13. Masuda H and Asahara T: Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 58: 390-398, 2003.
14. Rehman J, Li J, Orschell CM and March KL: Peripheral blood 'endothelial progenitor cells' are derived from monocytes/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169, 2003.
15. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M and Isner JM: VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18: 3964-3972, 1999.
16. Suriano R, Chaudhuri D, Johnson RS, Lambers E, Ashok BT, Kishore R and Tiwari RK: 17β-Estradiol mobilizes bone marrow-derived endothelial progenitor cells to tumors. Cancer Res 68: 6038-6042, 2008.
17. Ramsden JD: Angiogenesis in the thyroid gland. J Endocrinol 166: 475-480, 2000.
18. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin 59: 225-249, 2009.
19. Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, Devesa SS and McGlynn KA: Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev 18: 1174-1182, 2009.
20. Levi F, Franceschi S, Gulie C, Negri E and Vecchia CL: Female thyroid cancer: the role of reproductive and hormonal factors in Switzerland. Oncology 50: 309-315, 1993.
21. Furlanetto TW, Nguyen LQ and Jameson JL: Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology 140: 5705-5711, 1999.
22. Manole D, Schildknecht B, Gosnell B, Adams E and Derwahl M: Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 86: 1072-1077, 2001.
23. Rajoria S, Suriano R, Shanmugam A, Wilson YL, Schantz SP, Geliebter J and Tiwari RK: Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid 20: 33-41, 2010.
24. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow L, Copland JA, Smallridge RC and Haugen BR: Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab 93: 4331-4341, 2008.
25. Asahara T, Masuda H, Takahashi T, Kalka C, Patore C, Silver M, Marianne K, Magner M and Isner JM: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228, 1999.
26. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N, Kluge K, Schafer B, Hossfeld DK and Fiedler W: In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95: 3106-3112, 2000.
27. Khakhoo AY and Finkel T: Endothelial progenitor cell. Ann Rev Med 56: 79-101, 2005.
28. Dong F and Ha X-Q: Effect of endothelial progenitor cells in neovascularization and their application in tumor therapy. China Med J 123: 2454-2460, 2010.
29. Wu LC and Zhang WD: Clinical trials of antiangiogenesis therapy on gastric cancer. Gastroenterol Res 1: 14-19, 2008.
30. Kerbel RS: Antiangiogenic therapy: A universal chemosensitization strategy for cancer? Science 312: 1171-1175, 2006.